Use of natural release retardant in drug delivery system

Indian Drugs

Volumn 42, Issue 9, 2005, Pages 565-575

  Desai, A ^a   Shidhaye, S ^a   Malke, S ^a   Kadam, V ^a  

^a BHARATI VIDYAPEETH S COLLEGE OF PHARMACY   (India)

Author keywords

Natural release retardant

Indexed keywords

EID: 77953473634     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Encyclopedia Of Pharmaceutical Technology, Vol:8, James Swarbrick, James C. Boylan, Marcel Dekker, New York, 417-440,449-465.
2. Targeted And Controlled Drug Delivery System, Vyas and Khar, CBS Publishers and distributors, 2002, 487-488.
3. Dutta S., Karki R. et al, Liposomes Encapsulated Rifampicin And Isoniazid Ind. J. Pharm. Sci., 2000, 62, 384-387.
4. QI Zangand, Ying Jie deng et al, Studies On The Preparation And Characterization Of Thermosensitive Liposomes, Ind. J. Pharm. Sci., 2000, 62, 360-363.
5. Targeted And Controlled Drug Delivery System, Vyas and Khar, CBS Publishers and distributors, 2002, 490.
6. Realdon N. et al, Effect of Gelling Condition and Mechanical Treatment on Drug Availability from A Lipogel, Drug. Dev. Ind. Pharm., 2001, 27, 165-170. (Pubitemid 32207373)
7. Basima M., Madiha B. et al, Evaluation of The Effect Of Different Fatty Acids On The Percutaneous Absorption of Metaproterenol Sulfate, J. Pharm. Sci., 1996, 85, 101-104.
8. Leigi G. Martin et al, The Use of A Hydrophobic Matrix for The Sustained Release of A Highly Water-Soluble Drug, Drug Dev. Ind. Pharm. 2000, 26(1), 79-83.
9. Martez Rafiee-Terani and Ali Mehramizi, In Vitro Release Studies Of Pyroxycam From Oil-In-Water Creams And Hydroalcoholic Gel Topical Formulation, Drug Dev. Ind. Pharm. 2000, 26(4), 409-414.
10. Reddy M. N., Shirwaikar A. A., Rosin A. Polymer For Microencapsulation of Diltiazemhydrochloride for Sustained Release by Emulsion Solvent Evaporation Technique, Ind. J. Pharm. Sci., 2000, 61, 308-310
11. Pharmacognosy, Kokate C. K., fifteenth edition, Vallabh Prakashan, 132-134.
12. Chourasia M. K. and Jain S. K. Progress In Controlled And Novel Drug Delivery System, N.K. Jain, CBS Publishers and distributors, 2004, 410-411.
13. Chourasia M. K. and Jain S. K. Progress In Controlled And Novel Drug Delivery System, N.K. Jain, CBS Publishers and distributors, 2004, 419-422.
14. Microencapsulation and related drug processes, Vol: 20, Patric Deasy, Marcel Dekker, New York, 257.
15. Bhalerao S. S., Lalla J. K. et al, Studies on Controlled Release Suspension of Diltiazemhydrochloride Microspheres, Ind. J. Pharm. Sci., 2000, 62, 236-239.
16. Menon M., Kulkarni S. et al, Sustained Release Implant of Chloroquine Phosphate for Malaria Prophylaxis, Ind. J. Pharm. Sci., 2000, 62, 21-25. (Pubitemid 30126419)
17. Tozaki H. et al, Chitosan Capsules for Colon Specific Drug Delivery: Improvement of Insulin Absorption from The Rat Colon, J. Pharm. Sci., 1997, 86, 1016-1021. (Pubitemid 27382903)
18. Tozaki H. et al, Chitosan Capsules for Colon Specific Drug Delivery: Enhanced Localisation of 5-Aminosalicylic Acid in the Large Intestine Accelerates Healing of TNBS- Induced Colitis In Rats, J. Contrl. Rel. 2002, 82, 51-61.
19. Stubb B. et al, The Invitro Evaluation of ' Azo Containing Polysaccharide Gel ' For Colon Delivery,J. Contrl. Rel., 2001, 75, 103-114.
20. Gohel M. C., Patel M. M. Development of Modified Release Diltiazem hydrochloride Tablets Using Composite Index to Identify Optimal Formulation, Drug Dev. Ind. Pharm., 2003, 29, 565-574.
21. Murali Mohan G. V., Himshankar K. et al, Development Of New Controlled Release Formulation Of Flurbiprofen : Invitro-Invivo Correlation, Ind. J. Pharm. Sci., 2002, 64, 37-43.
22. Advances In Targeted And Novel Drug Delivery System, Jain N. K. CBS Publishers and distributors, 2003, 211.
23. Vemuri S. A Screening Technique To Study the Mechanical Strength of Gelatin Formulations, Drug. Dev. Ind. Pharm., 2000, 26 (10), 1115-1120.
24. Dong Sun Kim, Yun Jin Jung et al., Synthesis And Properties Of Dextran Linked Ampicillin, Drug Dev. Ind. Pharm., 2001, 27, 97-101.
25. Encyclopedia Of Pharmaceutical Technology, Vol: 10, James Swarbrick, James C. Boylan, Marcel Dekker, New York 153.
26. Mc Conville J. T., Patel N. et al, Use Of A Novel Modified TSI For The Evaluation Of Controlled Release Aerosol Formulations I, Drug Dev. Ind. Pharm., 2000, 26,1191-1198.
27. Jing-Hao Cui, Juhn- Su Goh et al., Preparation And Physical Characterization Of Alginate Micro Particles Using Air Automization Method, Drug Dev. Ind. Pharm., 2001, 27 (4), 309-319.
28. Gilberto Coppi et al., Chitosan-Alginate Micro Particles As A Protein Carrier, Drug Dev. Ind. Pharm., 2001, 27 (5), 393-400.
29. Uko-Nne S. P. et al., Dried Molasses As A Direct Compressible Matrix For Oral Controlled Release Delivery-I: Matrix Development And Drug Release, Drug Dev. Ind. Pharm., 1989, 15, 705-718.
30. Uko-Nne S. P. et al. Dried Molasses As A Direct Compressible Matrix For Oral Controlled Release Delivery-I: Release Mechanism and Characterization of Theophyllin from molasses- HPMC Matrix, Drug Dev. Ind. Pharm., 1989, 15, 719-741.
31. Meshali M. M et al., Physical Characterization And Release Behavior of Salbutamol sulfate Bead Prepared with Different Ionic Polysaccharides, Drug Dev. Ind. Pharm., 1998, 24,541-547. (Pubitemid 28273121)
32. Alhaique F. et al., Gellan for the Formulation of Sustained Delivery Beads, J. Contrl. Rel., 1996,42, 157-164. (Pubitemid 26319854)
33. Rizk S. et al., Physico-Chemical Characterization And Tableting Properties Of Sclleroglucan, Int. J. Pharm., 1944, 112, 125-131.
34. Alhaique F. et al., A Novel Co-Crosslinked Polysaccharide: Studies for A Controlled Delivery Matrix, J. Contrl. Rel., 1998, 55, 57-66. (Pubitemid 28477564)
35. Bhattacharya A. et al., Nanoparticular Antineoplastic Drug Delivery System Using Bovine Serum Albumin, Ind. J. Pharm. Sci., 2000, 62, 380-383.
36. Santhi K., Dhanaraj S. A. et al., Study On Formulation And Targeting Efficiency Of Amphotericin-B Nanospheres, Ind. J. Pharm. Sci., 2000, 62, 421-423. (Pubitemid 32422256)
37. Nagachi S. et al., Bio-Vectors For Tumor Therapy: Lipoprotein Mimicking Biovectorized Systems, Ind. J. Pharm. Sci., 2000, 62, 168-174.
38. Mishra P. R., Jain N. K. Progress In Controlled And Novel Drug Delivery System, N. K. Jain, CBS Publishers and distributors, 2004, 248-257.
39. Mishra P. R. and Jain N. K. Biotinylated Methotrexate Loaded Erythrocytes for Enhanced Liver Uptake. A Study on the Rat, Int. J. Pharm., 2002, 231 (2), 145-154.
40. Zaltzman A. B. et al., Enhanced Complement Susceptibility of Avidin-Biotin-Treated Human Erythrocyte Is A Consequence of Neutralization Of The Component Regulator Cd 59 And Decay Accelerating Factor, Biochem. J., 1995, 307, 651-656.
41. Vladimir R., Muzykantov et al, Erythrocyte Engineering For Drug Delivery And Targeting, Magnan and Mauro, 2002, 21.
42. Magnani M. et al., Red Blood Cells As An Antigen Delivery System, Biotechnol. Appl. Biochem, 1992, 16, 188-192.
43. Burrows F. et al., Vascular Targeting- A New Approach to the Therapy of Solid Tumors Pharmacol. Ther., 1994, 64, 155-174.
44. Myzykontov V. et al., Lung Is the Target Organ for Monoclonal Antibodies to Angiotensin Converting Enzyme, Lab. Invest. 1991, 64, 118-124.
45. Godfrey W. et al., Affinity Targeting Of Membrane Vesicles To Cell Surface, Exp. Cell Res., 1991, 135, 137-145.
46. Mishra P. R. and Jain N. K. Float Conjugated Doxorubisin Loaded Membrane Vesicles For Improved Cancer Therapy, Drug Delivery, 2003, 10, 4, 277-282.
47. Murli J. et al., Amyloid Insulin Interaction With Erythrocytes, Biochemistry and Cell biology, 2003, 81, 1, 51-59.
48. http://www.malariajournal.com/content/ 2/1/11.
49. http://www.pharmrev.org.
50. James W. Mc Ginity et al., Invitro Adsorption Of Various Pharmaceuticals To Montmorillonite, J. Pharm. Sci., 1976,65, 896-901.
51. James W. Mc Ginity et al., Sustained Release Appication Of Montmorillonite Interaction With Amphetamine Sulfate, J. Pharm. Sci., 1977, 66, 63-66. (Pubitemid 8022890)